Nebulized Versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary Study
- 30 June 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 29 (6) , 613-618
- https://doi.org/10.1016/j.jpainsymman.2004.08.016
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoeaBMJ, 2003
- The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trialAnnals of Oncology, 1999
- Nebulized opioids to treat dyspneaAmerican Journal of Hospice and Palliative Medicine®, 1999
- Dyspnoea in patients with advanced cancer: Incidence, causes and treatmentsCancer Treatment Reviews, 1998
- Nebulized Opioids in the Treatment of DyspneaJournal of Palliative Care, 1997
- Nebulized morphine for paroxysmal cough and dyspnea in a nursing home resident with metastatic cancerAmerican Journal of Hospice and Palliative Medicine®, 1997
- Systemic absorption of nebulized morphine compared with oral morphine in healthy subjectsPublished by Wiley ,1996
- Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease.Thorax, 1995
- Subcutaneous Morphine for Dyspnea in Cancer PatientsAnnals of Internal Medicine, 1993
- Effects of morphine on the dyspnea of terminal cancer patientsJournal of Pain and Symptom Management, 1990